Page last updated: 2024-09-04

gadolinium dtpa and 18f-fluoroethyl-l-tyrosine

gadolinium dtpa has been researched along with 18f-fluoroethyl-l-tyrosine in 3 studies

Compound Research Comparison

Studies
(gadolinium dtpa)
Trials
(gadolinium dtpa)
Recent Studies (post-2010)
(gadolinium dtpa)
Studies
(18f-fluoroethyl-l-tyrosine)
Trials
(18f-fluoroethyl-l-tyrosine)
Recent Studies (post-2010) (18f-fluoroethyl-l-tyrosine)
12,6546644,0511228112

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coenen, HH; Ewelt, C; Felsberg, J; Floeth, FW; Langen, KJ; Reifenberger, G; Sabel, M; Steiger, HJ; Stoffels, G; Stummer, W1
Ewelt, C; Felsberg, J; Floeth, FW; Langen, KJ; Sabel, M; Steiger, HJ; Stoffels, G; Stummer, W1
Avril, N; Hoimes, C; Hu, L; Lee, Z; Muzic, R; Sher, A; Valls, L1

Trials

1 trial(s) available for gadolinium dtpa and 18f-fluoroethyl-l-tyrosine

ArticleYear
Comparison of (18)F-FET PET and 5-ALA fluorescence in cerebral gliomas.
    European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:4

    Topics: Adult; Aged; Aminolevulinic Acid; Blood-Brain Barrier; Brain Neoplasms; Female; Gadolinium DTPA; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Spectrometry, Fluorescence; Tyrosine

2011

Other Studies

2 other study(ies) available for gadolinium dtpa and 18f-fluoroethyl-l-tyrosine

ArticleYear
Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence.
    Clinical neurology and neurosurgery, 2011, Volume: 113, Issue:7

    Topics: Adult; Aminolevulinic Acid; Biopsy; Brain Neoplasms; Carcinoma; Contrast Media; Female; Fluorescence; Gadolinium DTPA; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Monitoring, Intraoperative; Neurosurgical Procedures; Positron-Emission Tomography; Radiopharmaceuticals; Surgery, Computer-Assisted; Tyrosine

2011
Early response monitoring of receptor tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma using [F-18]fluorothymidine-positron emission tomography-magnetic resonance.
    Seminars in roentgenology, 2014, Volume: 49, Issue:3

    Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Contrast Media; Diffusion Magnetic Resonance Imaging; Gadolinium DTPA; Humans; Image Enhancement; Indoles; Kidney Neoplasms; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrroles; Radiopharmaceuticals; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome; Tyrosine

2014